Premium Diagnostics to establish holding company, conduct IPO by H2 of 2024
![](/images/markets/IPO.jpg)
Premium Diagnostics hired an English company as a financial advisor to establish a holding company for its offices in the United States, Saudi Arabia, the United Arab Emirates, and Egypt, to offer its shares on the stock exchange in the UAE or Saudi Arabia. The company plans to raise its capital from $14m to $24m to finance its expansion plans for the current year 2024.